SLANG Worldwide, Emerald Health, & Deepak Anand – Midas Letter RAW 158

-Normal: working on policy; working on amnesty
Deepak Anand, Cannabis Business Expert

Did You Know? Spiders and intoxicants

-CHronos (NASDAQ:CRON) chart: candle was well through Bollinger, correction; big move without any real catalysts
-cannabis market is either a lot of red or green; not a lot of sideways action
-always want to hear a company patent things (not all with pan out though)
-Emerald Health $500M market cap
Macroeconomics and Cannabis Analysis with Ben & Ed

-17 patents in process; see CBD big part of the future; THC also has therapeutic use; pushing ahead on both fronts for now
-biomass supply puts Emerald up with major players in the Canadian space
-huge opportunity to get CBD products (and others); developing patents
-expanding internationally? looking overseas; Andena extraction tech JV in Italy; Factors Group extraction, soft gel deal
-anticipate having to go to market again in the next few months
-raised $10.8M in December; spending quickly because of capital projects (Quebec facility expansion, and in Vancouver) and JB with Emerald Health Naturals
-Q4 report out at the end of April
-medical, dried flower, oil right now
-data showing shift toward extracted products
-vast majority will go to the recreational market as dried flower
-great partnership, they had expertise in growing; over last 18 months building out 1.1M square foot greenhouse, first crops out of that location last summer in Delta; expect to have entire facility in cultivation in first half of 2019
-JV with Village Farms international (they’ve doubled in the last two sessions)
-developing health and wellness products
Emerald Health Therapeutics (CVE:EMH) CFO Rob Hill

-S&P chart: drifting outside channel
-SLANG Worldwide: Canopy backing
Macroeconomics and Cannabis Analysis with Ben & Ed

-2019 catalysts: more growth, products on more shelves,
-CBD products
-ton of competition at the ground (brand) level;
-self distribute (no one has the scale that we have)
-dominant portfolio of brands across all categories in about 2600 stores; original MSO (before it was an acronym)
-Branded Bud,
-getting SLANG brands into Canopy stores in the fall
-Canopy partnership (post Metrum transaction); Canopy saw an opportunity to get involved in brands (limit on what they can do because of the US)
-goal getting their brands on shelves
-capital light: extraction through retail distribution
-don’t do any cultivation, (capital intensive) retail (don’t want to compete with customers -retailers)
-went public in January
-backed by Canopy Growth
-cannabis CPG company; focused on creating regional brands
SLANG Worldwide (CNSX:SLNG) CEO Peter Miller

-as the drug coverage becomes more apparent, companies with deals with Shoppers will be big value
-WeedMD available on Shoppers; not moving as a catalyst though; some of the value already built in
-Canopy Growth (TSE:WEED) recent move without a big catalyst
-ML CSE index: slightly up today
-ML Venture index: Khiron (CVE:KHRN) still holding up well
-MSOs (last week lost 3-5%), HMMJ/CAN MJ stocks (lost double that last week)
-concern over earnings this week
-ML small cap index: all down; about 3%
-ML large cap index: Tier 1s have had a bad day
-zombifiction of the market (can’t raise interest rates) where the US economy is going
-Japanese economic issues (now and historically)
-US economy debt
-interest rates
Macroeconomics and Cannabis Analysis with Ben & Ed

-earnings reporting
-WeedMD (CVE:WMD) completes first shipment to SHoppers Drug Mart
-VIVO Cannabis (CVE:VIVO) subsidiary receives Health Canada license
-TerAScend Corp (CNSX:TER) purchase agreement (Apothecarium)
-Green Growth Brands (CNSX:GGB) entered into agreement with Simon (NYSE:SPG) for retail locations
-Flowr One (CNSX:FONE) enters into financing agreement
-Aurora Cannabis (TSE:ACB) completes first delivery of cannabis oil to UK
Midas Letter NEws

-David Rosenberg: tightening cycle
-IMF: where’s growth coming from
Macroeconomics and Cannabis Analysis with Ben & Ed

Midas Letter RAW highlights the stocks and stories to watch in the Canadian markets today. Ben Smith and Ed Milewski provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business.


Check out our website:


SUBSCRIBE to our YouTube:

SUBSCRIBE to our 2nd YouTube Channel – Midas Letter Clips:

SUBSCRIBE to our Newsletter:

Download Our Podcast on iTunes:


Follow Us on Twitter:

Like Us on Instagram:

Like Us on Facebook:




Leave a Reply